Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

被引:0
|
作者
Laura Broutier
Gianmarco Mastrogiovanni
Monique MA Verstegen
Hayley E Francies
Lena Morrill Gavarró
Charles R Bradshaw
George E Allen
Robert Arnes-Benito
Olga Sidorova
Marcia P Gaspersz
Nikitas Georgakopoulos
Bon-Kyoung Koo
Sabine Dietmann
Susan E Davies
Raaj K Praseedom
Ruby Lieshout
Jan N M IJzermans
Stephen J Wigmore
Kourosh Saeb-Parsy
Mathew J Garnett
Luc JW van der Laan
Meritxell Huch
机构
[1] The Wellcome Trust/CRUK Gurdon Institute,Department of Surgery
[2] University of Cambridge,Department of Surgery
[3] Wellcome Trust—Medical Research Council Stem Cell Institute,Department of Histopathology
[4] University of Cambridge,Department of Hepato Pancreato Biliary Surgery
[5] Erasmus MC–University Medical Center,Department of Clinical Surgery
[6] Wellcome Trust Sanger Institute,Department of Physiology
[7] Wellcome Trust Genome Campus,undefined
[8] University of Cambridge and NIHR Cambridge Biomedical Research Centre,undefined
[9] Cambridge University Hospitals NHS Foundation Trust,undefined
[10] Cambridge University Hospitals NHS Foundation Trust,undefined
[11] Royal Infirmary of Edinburgh,undefined
[12] Development and Neuroscience,undefined
[13] University of Cambridge,undefined
来源
Nature Medicine | 2017年 / 23卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tumor organoids derived from the most common subtypes of primary liver cancer recapitulate the histologic and molecular features of the tissues of origin, even after long-term culture. These in vitro models, as well as those for colorectal cancer reported in Crespo et al. in a previous issue, are amenable for drug screening and allow the identification of therapeutic approaches with potential for cancer treatment.
引用
收藏
页码:1424 / 1435
页数:11
相关论文
共 50 条
  • [1] Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
    Broutier, Laura
    Mastrogiovanni, Gianmarco
    Verstegen, Monique M. A.
    Francies, Hayley E.
    Gavarro, Lena Morrill
    Bradshaw, Charles R.
    Allen, George E.
    Arnes-Benito, Robert
    Sidorova, Olga
    Gaspersz, Marcia P.
    Georgakopoulos, Nikitas
    Koo, Bon-Kyoung
    Dietmann, Sabine
    Davies, Susan E.
    Praseedom, Raaj K.
    Lieshout, Ruby
    IJzermans, Jan N. M.
    Wigmore, Stephen J.
    Saeb-Parsy, Kourosh
    Garnett, Mathew J.
    van der Laan, Luc J. W.
    Huch, Meritxell
    [J]. NATURE MEDICINE, 2017, 23 (12) : 1424 - +
  • [2] Organoid cultures for cancer modeling
    Yan, Helen H. N.
    Chan, April S.
    Lai, Frank Pui-Ling
    Leung, Suet Yi
    [J]. CELL STEM CELL, 2023, 30 (07) : 917 - 937
  • [3] Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening
    Jie Li
    Huawei Xu
    Lixing Zhang
    Lele Song
    Dan Feng
    Xiaobo Peng
    Meihong Wu
    Yang Zou
    Bin Wang
    Lixing Zhan
    Guoqiang Hua
    Xianbao Zhan
    [J]. Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2637 - 2647
  • [4] Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening
    Li, Jie
    Xu, Huawei
    Zhang, Lixing
    Song, Lele
    Feng, Dan
    Peng, Xiaobo
    Wu, Meihong
    Zou, Yang
    Wang, Bin
    Zhan, Lixing
    Hua, Guoqiang
    Zhan, Xianbao
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (11) : 2637 - 2647
  • [5] Strategies for Generating Human Pluripotent Stem Cell-Derived-Organoid Culture for Disease Modeling, Drug Screening, and Regenerative Therapy
    Gania, Zakiya
    Noorintan, Syarifah Tiara
    Septiari, Ni Putu Diah Pradnya
    Fitriany, Dhea Sandra
    Torizal, Fuad Gandhi
    [J]. FUTURE PHARMACOLOGY, 2022, 2 (03): : 360 - 376
  • [6] Patient-Derived Organoid Cultures for Personalized Therapies and Targeted Drug Screening Applications
    Contreras, Constanza Tapia
    Schneider, Gunter
    Muller, Denise
    Mirzakhani, Kimia
    Conrads, Karly
    Kaulfuss, Silke
    Beissbarth, Tim
    Salinas, Gabriela
    Beyer, Nils
    Reinlander, Sophia
    Sax, Ulrix
    Hessmann, Elisabeth
    Ellenrieder, Volker
    Strobel, Philipp
    Ghadimi, Michael
    [J]. CANCER RESEARCH, 2024, 84 (17)
  • [7] Long-term engineered cultures of iPSC-derived human hepatocytes for disease modeling and drug screening
    Khetani, Salman
    Berger, Dustin
    Ware, Brenton R.
    Davidson, Matthew
    [J]. HEPATOLOGY, 2014, 60 : 1186A - 1186A
  • [8] Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
    Li, Zhichao
    Qian, Youhui
    Li, Wujiao
    Liu, Lisa
    Yu, Lei
    Liu, Xia
    Wu, Guodong
    Wang, Youyu
    Luo, Weibin
    Fang, Fuyuan
    Liu, Yuchen
    Song, Fei
    Cai, Zhiming
    Chen, Wei
    Huang, Weiren
    [J]. ISCIENCE, 2020, 23 (08)
  • [9] Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing
    Zu, Ming
    Hao, Xinyu
    Ning, Jing
    Zhou, Xin
    Gong, Yueqing
    Lang, Yanfei
    Xu, Weichao
    Zhang, Jing
    Ding, Shigang
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
  • [10] Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer
    Xian, Linfeng
    Zhao, Pei
    Chen, Xi
    Wei, Zhimin
    Ji, Hongxiang
    Zhao, Jun
    Liu, Wenbin
    Li, Zishuai
    Liu, Donghong
    Han, Xue
    Qian, Youwen
    Dong, Hui
    Zhou, Xiong
    Fan, Junyan
    Zhu, Xiaoqiong
    Yin, Jianhua
    Tan, Xiaojie
    Jiang, Dongming
    Yu, Hongping
    Cao, Guangwen
    [J]. CELLULAR ONCOLOGY, 2022, 45 (05) : 1019 - 1036